KALB; Oskar
Patent Applications and Registrations
Patent applications and USPTO patent grants for KALB; Oskar.The latest application filed is for "high drug load tablet".
- KALB; Oskar - Loerrach DE
- Kalb; Oskar - Basel CH
- Kalb; Oskar - Lorrach DE
| Patent | Date |
|---|---|
| High Drug Load Tablet App 20160101105 - LUFTENSTEINER; Christian-Peter ; et al. | 2016-04-14 |
| High Drug Load Tablet App 20150209291 - LUFTENSTEINER; Christian-Peter ; et al. | 2015-07-30 |
| High drug load tablet Grant 9,011,911 - Luftensteiner , et al. April 21, 2 | 2015-04-21 |
| Stabilized Amorphous Forms of Imatinib Mesylate App 20140323495 - Goncalves; Elisabete ; et al. | 2014-10-30 |
| High Drug Load Tablet App 20140135340 - Luftensteiner; Christian-Peter ; et al. | 2014-05-15 |
| Stabilized Amorphous Forms of Imatinib Mesylate App 20130225598 - Goncalves; Elisabete ; et al. | 2013-08-29 |
| Stabilized Amorphous Forms of Imatinib Mesylate App 20130022672 - Goncalves; Elisabete ; et al. | 2013-01-24 |
| Pharmaceutical compositions comprising fluvastatin Grant 8,303,987 - Kalb , et al. November 6, 2 | 2012-11-06 |
| High Drug Load Tablet App 20120177737 - LUFTENSTEINER; Christian-Peter ; et al. | 2012-07-12 |
| Oral Controlled Release Formulations App 20110038897 - SHAH; Rajen ; et al. | 2011-02-17 |
| Pharmaceutical Compositions Comprising Fluvastatin App 20100303919 - Kalb; OSKAR ; et al. | 2010-12-02 |
| High Drug Load Tablet App 20100203133 - LUFTENSTEINER; Christian-Peter ; et al. | 2010-08-12 |
| Stabilized Amorphous Forms Of Imatinib Mesylate App 20100178336 - Goncalves; Elisabete ; et al. | 2010-07-15 |
| Pharmaceutical Compositions App 20100022565 - Buhl; Thomas ; et al. | 2010-01-28 |
| Solid Dispersion Of A Neurokinin Antagonist App 20100015225 - Diederich; Anke ; et al. | 2010-01-21 |
| Pharmaceutical compositions containing terbinafin and use thereof App 20080286356 - Alles; Rainer ; et al. | 2008-11-20 |
| Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin App 20080213385 - Kalb; Oskar ; et al. | 2008-09-04 |
| Fast Release Composition Including Melt Granules of a Moisture Sensitive Drug and Process for Manufacturing Thereof App 20080050443 - Kowalski; James ; et al. | 2008-02-28 |
| Oral matrix formulations comprising licarbazepine App 20070196488 - Kalb; Oskar ; et al. | 2007-08-23 |
| Disintegrating tablets comprising licarb azepine App 20070190143 - Kalb; Oskar ; et al. | 2007-08-16 |
| Sustained release oral formulations App 20070053982 - Ogorka; Jorg ; et al. | 2007-03-08 |
| Oral controlled release formulations App 20060246101 - Shah; Rajen ; et al. | 2006-11-02 |
| Combined capsule and tablets Grant D530,814 - Bonny , et al. October 24, 2 | 2006-10-24 |
| Pharmaceutical compositions comprising fluvastatin App 20060127474 - Kalb; Oskar ; et al. | 2006-06-15 |
| Combine capsule and tablets Grant D520,635 - Bonny , et al. May 9, 2 | 2006-05-09 |
| High drug load tablet App 20050267125 - Luftensteiner, Christian-Peter ; et al. | 2005-12-01 |
| Sustained release oral formulations App 20050175706 - Ogorka, Jorg ; et al. | 2005-08-11 |
| Pharmaceutical compositions containig terbinafin and use thereof App 20040198838 - Alles, Rainer ; et al. | 2004-10-07 |
| Sustained release oral formulations App 20030203025 - Ogorka, Jorg ; et al. | 2003-10-30 |
| Pharmaceutical compositions comprising fluvastatin App 20030171419 - Kalb, Oskar ; et al. | 2003-09-11 |
| Controlled release oral compositions comprising rivastigmine Grant 6,565,883 - Ogorka , et al. May 20, 2 | 2003-05-20 |
| Sustained release oral formulations App 20030039692 - Ogorka, Jorg ; et al. | 2003-02-27 |
| Sustained release oral formulations App 20010033866 - Ogorka, Jorg ; et al. | 2001-10-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 